United Kingdom, London 
Professor Justin Stebbing is a distinguished British oncologist, researcher, and academic leader with extensive contributions to cancer biology, translational research, and drug development. He currently serves as Editor-in-Chief of Oncogene and is a Professor of Biomedical Sciences at Anglia Ruskin University, Cambridge, as well as a Visiting Professor of Oncology at Imperial College London.
Education & Training
Professor Stebbing completed his medical education at the University of Oxford, followed by clinical training and residency at Johns Hopkins University. He later earned a PhD in Medicine and Immunology from Imperial College London. He is a Fellow of the Royal College of Physicians (FRCP) and the Royal College of Pathologists (FRCPath).
Professional Roles & Leadership
In addition to his academic appointments, Professor Stebbing holds multiple leadership and advisory roles across clinical, scientific, and biotech sectors, including:
- Consultant Oncologist, London Lauriston Clinic and Phoenix Hospital Group
- Senior Vice President for Clinical Strategy and Innovation, Graviton Bioscience
- Board Member and Chair, Portage Biotech
- Chair of the Scientific Advisory Board, Zephyr AI
He is also actively involved in advisory roles for several biotechnology and AI-driven healthcare companies.
Research & Scientific Contributions
Professor Stebbing has authored over 700 peer-reviewed publications in leading journals such as The Lancet, New England Journal of Medicine, Nature Medicine, and Journal of Clinical Oncology. His research focuses on:
- Target discovery and gene regulation
- Non-coding RNA biology and cancer stem cells
- Clinical trials and development of novel therapeutics
- Biomarkers and access to biologic therapies globally
He has made significant contributions to immuno-oncology, including research on leveraging the immune system to treat cancer, particularly using HIV-related mechanisms as a model.
Awards & Honors
- Elected Member, American Society for Clinical Investigation
- NIHR Research Translational Professor (UK Government)
- Fellow of the Royal College of Physicians and Royal College of Pathologists
Academic & Editorial Contributions
Professor Stebbing has been Editor-in-Chief of Oncogene (Springer Nature) since 2016, overseeing one of the leading journals in cancer research. He has also served on multiple international advisory boards and continues to influence oncology research, policy, and innovation globally.
Research & Innovation Interests
His work bridges academia, clinical oncology, and investment, with a strong focus on:
- Precision oncology
- Artificial intelligence in medicine
- Drug development and innovation
- Global access to cancer therapies
All information is sourced from publicly available materials.